Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Hepatol. Aug 27, 2022; 14(8): 1584-1597
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1584
Table 3 Patient outcomes following Sengstaken-Blakemore Tube insertion
Variable
Value (n = 80)
Length of stay, d
Total hospital LOS11.0 (7.0, 19.5)
ICU LOS4.90 (2.3, 9.1)
Duration of mechanical ventilation, h89.5 (39.3, 153.8)
Blood product transfusion
Packed red cells, units6 (4, 10)
Platelets, units1 (0, 3)
Fresh frozen plasma, units2 (1, 6)
Achieved primary haemostasis73 (91.3)
Re-bleeding25 (34.2)
Complications of SBT19 (34.5)
Mucosal ulceration and tears (without perforation)17 (89.5)
Aspiration pneumonia4 (21.0)
Perforation1 (5.3)
TIPS
Underwent TIPS17 (21.3)
Time to TIPS from SBT, d2.95 (1.4, 4.1)
Survival
Survived hospital admission41 (51.2)
Alive at 6 wk41 (51.2)
Alive at 26 wk39 (48.8)
Alive at 52 wk37 (46.3)